{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-058141","form_type":"8-K","ticker":"BRNS","cik":"0001828185","company_name":"Barinthus Biotherapeutics plc.","filed_at":"2025-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.979212+00:00","generated_at":"2026-05-19T15:59:28.865318+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Barinthus Biotherapeutics shareholders approve all proposals at 2025 AGM","bullets":["Resolutions to re-elect directors Pierre A. Morgon and Joseph C. Scheeren passed with ~98.9% of votes cast.","PricewaterhouseCoopers LLP re-appointed as U.K. statutory auditors and ratified as independent auditor for FY2025.","Shareholders approved director remuneration policy and advisory compensation report for FY2024.","No dividend recommended for FY2024; statutory accounts received and noted.","Quorum achieved with 26,993,016 ordinary shares present or represented (66.9% of entitled shares)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-058141","json":"https://secwatch.observer/filing/0001104659-25-058141.json","markdown":"https://secwatch.observer/filing/0001104659-25-058141.md","text":"https://secwatch.observer/filing/0001104659-25-058141.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828185/000110465925058141/0001104659-25-058141-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828185/000110465925058141/tm2517545d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T15:59:28.865318+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}